Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
E-Duction was a medical device company that focused on developing innovative treatments for obesity. The company's primary technology involved a gastric electrical stimulation device designed to induce early satiety and assist in weight loss. Despite early development efforts and clinical interest in the field of neuromodulation for metabolic disorders, the company is no longer active. Its work contributed to the broader understanding of how electrical stimulation can influence gastrointestinal motility and appetite regulation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on E-Duction.